Breaking News Instant updates and real-time market news.

TLGHF

Telenet

$0.00 /

+ (+0.00%)

05:15
06/25/19
06/25
05:15
06/25/19
05:15

Telenet downgraded to Neutral from Buy at UBS

TLGHF Telenet
$0.00 /

+ (+0.00%)

11/05/18 BofA
Telenet downgraded to Underperform from Buy at BofA/Merrill
09/26/18 Barclays
Telenet downgraded to Equal Weight from Overweight at Barclays

TODAY'S FREE FLY STORIES

Hot Stocks
Domino's Pizza opens first store in Croatia » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
DPZ

Domino's Pizza

$391.61 /

+4.46 (+1.15%)

Domino's Pizza is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

07/27/20 Stephens
McDonald's, Domino's among restaurant stocks to own now, says Stephens
07/22/20 Northcoast
Domino's Pizza not using aggressive discounts to drive growth, says Northcoast
07/17/20 MKM Partners
Domino's Pizza price target raised to $385 from $375 at MKM Partners
07/17/20 Deutsche Bank
Domino's Pizza price target raised to $404 from $333 at Deutsche Bank
DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

Hot Stocks
Kinnevik announces support for proposed Teladoc Health and Livongo merger » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

, TDOC

Teladoc

$249.11 /

+11.77 (+4.96%)

Kinnevik AB, which is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
07/30/20 JPMorgan
Teladoc price target raised to $266 from $240 at JPMorgan
07/30/20 Credit Suisse
Teladoc price target raised to $225 from $165 at Credit Suisse
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

  • 12
    Dec
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

Hot Stocks
Constellation Pharmaceuticals announces 2020 milestones » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
CNST

Constellation Pharmaceuticals

$27.85 /

-0.58 (-2.04%)

The Company anticipates…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

06/24/20 JMP Securities
Constellation Pharmaceuticals initiated with a Market Perform at JMP Securities
06/12/20 RBC Capital
Constellation Pharmaceuticals data better than the prior cut, says RBC Capital
05/07/20 H.C. Wainwright
Constellation price target raised to $75 from $50 at H.C. Wainwright
03/11/20 BMO Capital
Constellation Pharmaceuticals price target lowered to $35 from $42 at BMO Capital
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

  • 17
    Jun
  • 11
    Dec
General news
FX Update: The dollar is down for a second day » 07:15
08/05/20
08/05
07:15
08/05/20
07:15

FX Update: The dollar is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Constellation expects cash to fund operations in mid-2023 » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
CNST

Constellation Pharmaceuticals

$27.85 /

-0.58 (-2.04%)

Constellation expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

06/24/20 JMP Securities
Constellation Pharmaceuticals initiated with a Market Perform at JMP Securities
06/12/20 RBC Capital
Constellation Pharmaceuticals data better than the prior cut, says RBC Capital
05/07/20 H.C. Wainwright
Constellation price target raised to $75 from $50 at H.C. Wainwright
03/11/20 BMO Capital
Constellation Pharmaceuticals price target lowered to $35 from $42 at BMO Capital
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

  • 17
    Jun
  • 11
    Dec
Earnings
BrainStorm reports Q2 EPS (25c), consensus (26c) » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
BCLI

BrainStorm

$13.33 /

-0.7 (-4.99%)

Cash, cash equivalents,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

07/08/20 Maxim
BrainStorm price target raised to $20 from $9 at Maxim
BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

Hot Stocks
Adicet Bio receives $10M product development milestone from Regeneron » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
REGN

Regeneron

$647.09 /

+1.76 (+0.27%)

, TORC

resTORbio

$2.59 /

+0.035 (+1.37%)

Adicet Bio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

TORC resTORbio
$2.59 /

+0.035 (+1.37%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 SunTrust
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
TORC resTORbio
$2.59 /

+0.035 (+1.37%)

04/29/20 Evercore ISI
resTORbio upgraded to Outperform from In Line at Evercore ISI
11/15/19 Wedbush
resTORbio downgraded to Neutral from Outperform at Wedbush
11/15/19 Guggenheim
resTORbio downgraded to Neutral from Buy at Guggenheim
11/15/19 Cantor Fitzgerald
resTORbio downgraded to Neutral from Overweight at Cantor Fitzgerald
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

TORC resTORbio
$2.59 /

+0.035 (+1.37%)

  • 27
    May
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

Earnings
Rocket Pharmaceuticals reports Q2 EPS (45c), consensus (51c) » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
RCKT

Rocket Pharmaceuticals

$24.87 /

+0.07 (+0.28%)

"During this…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$24.87 /

+0.07 (+0.28%)

RCKT Rocket Pharmaceuticals
$24.87 /

+0.07 (+0.28%)

07/21/20 Piper Sandler
Rocket shares should be owned through year-end, says Piper Sandler
07/02/20 JPMorgan
Rocket Pharmaceuticals initiated with an Overweight at JPMorgan
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
RCKT Rocket Pharmaceuticals
$24.87 /

+0.07 (+0.28%)

  • 11
    Dec
Earnings
Constellation Pharmaceuticals reports Q1 EPS (70c), consensus (63c) » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
CNST

Constellation Pharmaceuticals

$27.85 /

-0.58 (-2.04%)

"Having seen signals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

06/24/20 JMP Securities
Constellation Pharmaceuticals initiated with a Market Perform at JMP Securities
06/12/20 RBC Capital
Constellation Pharmaceuticals data better than the prior cut, says RBC Capital
05/07/20 H.C. Wainwright
Constellation price target raised to $75 from $50 at H.C. Wainwright
03/11/20 BMO Capital
Constellation Pharmaceuticals price target lowered to $35 from $42 at BMO Capital
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

  • 17
    Jun
  • 11
    Dec
Earnings
Nexstar reports Q2 EPS $2.13, consensus $1.18 » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
NXST

Nexstar

$89.45 /

+0.7 (+0.79%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXST Nexstar
$89.45 /

+0.7 (+0.79%)

NXST Nexstar
$89.45 /

+0.7 (+0.79%)

06/22/20 Benchmark
Nexstar price target raised to $125 from $120 at Benchmark
05/07/20 Wells Fargo
Nexstar price target raised to $88 from $81 at Wells Fargo
05/07/20 B. Riley FBR
Nexstar price target raised to $115 from $110 at B. Riley FBR
05/05/20 B. Riley FBR
Nexstar price target lowered to $110 from $139 at B. Riley FBR
NXST Nexstar
$89.45 /

+0.7 (+0.79%)

Earnings
GasLog reports Q2 EPS 3c, consensus 0c » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
GLOG

GasLog

$3.16 /

+0.145 (+4.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOG GasLog
$3.16 /

+0.145 (+4.81%)

GLOG GasLog
$3.16 /

+0.145 (+4.81%)

06/23/20 Fearnley
GasLog downgraded to Hold from Buy at Fearnley
06/02/20 Pareto
GasLog downgraded to Sell from Hold at Pareto
03/31/20 Pareto
GasLog upgraded to Hold from Sell at Pareto
03/09/20 DNB Markets
GasLog downgraded to Hold from Buy at DNB Markets
GLOG GasLog
$3.16 /

+0.145 (+4.81%)

Earnings
Charles River raises FY20 adj. EPS view to $7.05-$7.35 from $6.75-$7.10 » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
CRL

Charles River

$203.78 /

-3.69 (-1.78%)

Consensus $6.91. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRL Charles River
$203.78 /

-3.69 (-1.78%)

CRL Charles River
$203.78 /

-3.69 (-1.78%)

07/21/20 UBS
Charles River price target raised to $236 from $200 at UBS
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
05/26/20 Argus
Charles River price target raised to $190 from $150 at Argus
CRL Charles River
$203.78 /

-3.69 (-1.78%)

Hot Stocks
Bausch Health resolves Canadian securities class action » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
BHC

Bausch Health

$18.99 /

-0.13 (-0.68%)

Bausch Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

06/17/20 H.C. Wainwright
Bausch Health price target raised to $64 from $50 at H.C. Wainwright
06/03/20 Jefferies
Duobrii could become a key revenue driver for Bausch Health, says Jefferies
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Bausch Health initiated with a Buy at Citi
BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

Earnings
Starwood Property reports Q2 core EPS 43c, consensus 42c » 07:12
08/05/20
08/05
07:12
08/05/20
07:12
STWD

Starwood Property

$14.93 /

+0.03 (+0.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

05/05/20 B. Riley FBR
Starwood Property price target lowered to $18 from $27 at B. Riley FBR
04/27/20 Credit Suisse
Starwood Property price target lowered to $16 from $26 at Credit Suisse
12/02/19 Wells Fargo
Starwood Property initiated with an Outperform at Wells Fargo
08/14/19 Raymond James
Starwood Property price target raised to $27 from $24 at Raymond James
STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

Recommendations
Enphase Energy price target raised to $90 from $70 at Roth Capital » 07:12
08/05/20
08/05
07:12
08/05/20
07:12
ENPH

Enphase Energy

$69.05 /

+7.84 (+12.81%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

07/27/20 Roth Capital
Enphase Energy price target raised to $70 from $60 at Roth Capital
07/24/20
Fly Intel: Top five analyst initiations
07/24/20 JMP Securities
Enphase Energy initiated with a Market Perform at JMP Securities
06/29/20 Needham
Enphase Energy initiated with a Buy at Needham
ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

Hot Stocks
New York Times sees Q3 total subscription revenues up 10% » 07:12
08/05/20
08/05
07:12
08/05/20
07:12
NYT

New York Times

$46.81 /

+0.93 (+2.03%)

Sees Q3 total advertising…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
06/15/20 JPMorgan
New York Times price target raised to $50 from $42 at JPMorgan
06/12/20 Loop Capital
News Corp price target raised to $18 from $16 at Loop Capital
04/23/20 Evercore ISI
New York Times downgraded to In Line from Outperform at Evercore ISI
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

Recommendations
Evolent Health price target raised to $20 from $15 at Truist » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
EVH

Evolent Health

$12.75 /

+0.755 (+6.29%)

Truist analyst Sandy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

07:00 Today Cantor Fitzgerald
Evolent Health price target raised to $13 from $10 at Cantor Fitzgerald
07/06/20 KeyBanc
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
07/06/20 KeyBanc
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
06/26/20 JPMorgan
Evolent Health price target lowered to $8 from $11 at JPMorgan
EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

Earnings
Charles River reports Q2 EPS $1.58, consensus $1.26 » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
CRL

Charles River

$203.78 /

-3.69 (-1.78%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRL Charles River
$203.78 /

-3.69 (-1.78%)

CRL Charles River
$203.78 /

-3.69 (-1.78%)

07/21/20 UBS
Charles River price target raised to $236 from $200 at UBS
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
05/26/20 Argus
Charles River price target raised to $190 from $150 at Argus
CRL Charles River
$203.78 /

-3.69 (-1.78%)

Earnings
GasLog Partners reports Q2 EPS 44c, consensus 28c » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
GLOP

GasLog Partners

$3.94 /

+0.02 (+0.51%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

04/30/20 BTIG
GasLog Partners cut to Neutral at BTIG on valuation
04/30/20 BTIG
GasLog Partners downgraded to Neutral from Buy at BTIG
02/07/20 Citi
GasLog Partners downgraded to Neutral from Buy at Citi
02/07/20 Citi
GasLog downgraded to Neutral from Buy at Citi
GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

Earnings
InMode sees FY20 revenue $156M-$160M, consensus $143.04M » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
INMD

InMode

$32.92 /

-0.53 (-1.58%)

InMode said, "We…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
11/06/19 Barclays
InMode price target raised to $45 from $27 at Barclays
11/06/19 Baird
InMode price target raised to $45 from $27 at Baird
INMD InMode
$32.92 /

-0.53 (-1.58%)

  • 08
    Aug
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

Earnings
New York Times reports Q2 adj. EPS 18c, consensus 1c » 07:10
08/05/20
08/05
07:10
08/05/20
07:10
NYT

New York Times

$46.81 /

+0.93 (+2.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
06/15/20 JPMorgan
New York Times price target raised to $50 from $42 at JPMorgan
06/12/20 Loop Capital
News Corp price target raised to $18 from $16 at Loop Capital
04/23/20 Evercore ISI
New York Times downgraded to In Line from Outperform at Evercore ISI
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

Earnings
InMode reports Q2 adjusted EPS 24c, consensus (6c) » 07:10
08/05/20
08/05
07:10
08/05/20
07:10
INMD

InMode

$32.92 /

-0.53 (-1.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
11/06/19 Barclays
InMode price target raised to $45 from $27 at Barclays
11/06/19 Baird
InMode price target raised to $45 from $27 at Baird
INMD InMode
$32.92 /

-0.53 (-1.58%)

  • 08
    Aug
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

Earnings
Middleby reports Q2 adj. EPS 55c, consensus 41c » 07:10
08/05/20
08/05
07:10
08/05/20
07:10
MIDD

Middleby

$85.68 /

+1.74 (+2.07%)

Reports Q2 revenue $472M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MIDD Middleby
$85.68 /

+1.74 (+2.07%)

MIDD Middleby
$85.68 /

+1.74 (+2.07%)

07/17/20 Citi
Middleby price target raised to $90 from $85 at Citi
06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 KeyBanc
Middleby upgraded to Overweight at KeyBanc on valuation, secular dynamics
06/29/20 KeyBanc
Middleby upgraded to Overweight from Sector Weight at KeyBanc
MIDD Middleby
$85.68 /

+1.74 (+2.07%)

MIDD Middleby
$85.68 /

+1.74 (+2.07%)

Earnings
Intec Pharma reports Q2 EPS (5c), consensus (5c) » 07:09
08/05/20
08/05
07:09
08/05/20
07:09
NTEC

Intec Pharma

$0.43 /

+0.017 (+4.11%)

CEO Jeffrey Meckler said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTEC Intec Pharma
$0.43 /

+0.017 (+4.11%)

11/14/19 Roth Capital
Intec Pharma may pursue partnership after failed trial, says Roth Capital
10/11/19 Roth Capital
Intec Pharma downgraded to Neutral from Buy at Roth Capital
08/07/19 H.C. Wainwright
Intec Pharma downgraded to Neutral from Buy at H.C. Wainwright
NTEC Intec Pharma
$0.43 /

+0.017 (+4.11%)

  • 31
    Jan
NTEC Intec Pharma
$0.43 /

+0.017 (+4.11%)

Earnings
Surgery Partners reports Q2 EPS (86c), consensus (69c) » 07:09
08/05/20
08/05
07:09
08/05/20
07:09
SGRY

Surgery Partners

$15.99 /

+0.55 (+3.56%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGRY Surgery Partners
$15.99 /

+0.55 (+3.56%)

04/27/20 Benchmark
Surgery Partners upgraded to Buy on faster recovery timeline at Benchmark
04/27/20 Benchmark
Surgery Partners upgraded to Buy from Hold at Benchmark
04/21/20
Envision bankruptcy report has limited read-throughs, says Benchmark
03/24/20 RBC Capital
Surgery Partners price target lowered to $14 from $19 at RBC Capital
SGRY Surgery Partners
$15.99 /

+0.55 (+3.56%)

SGRY Surgery Partners
$15.99 /

+0.55 (+3.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.